ORGS
Orgenesis Inc.
Price Chart
Latest Quote
$0.58
+0.00 (+0.00%)
Current Price
| Previous Close | $0.58 |
| Open | $0.91 |
| Day High | $0.91 |
| Day Low | $0.91 |
| Volume | 100 |
Stock Information
| Shares Outstanding | 9.80M |
| Total Debt | $17.30M |
| Cash Equivalents | $204K |
| Revenue | $1.03M |
| Net Income | $-48.16M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $5.68M |
| EPS (TTM) | $-11.44 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $20.18M |
| Sales | $1.03M |
| Income | $-48.16M |
| Book/sh | $-7.25 |
| Cash/sh | $0.02 |
| Employees | 77 |
Financial Ratios
| Quick Ratio | 0.00 |
| Current Ratio | 0.03 |
Returns & Margins
| ROA | -204.48% |
| Gross Margin | -86.28% |
| Operating Margin | -2196.25% |
Ownership
| Insider Ownership | 46.42% |
| Institutional Ownership | 0.52% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 0.95 |
| P/S | 5.49 |
| P/B | -0.08 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.42 |
| SMA50 | $0.38 |
| SMA200 | $0.40 |
| RSI | 41.82 |
| ATR | 0.1693 |
| Shares Float | 8.23M |
| Short Float | 1.33% |
| Short Ratio | 2.39 |
| Volatility | 2.97 |
Performance History
| Week | -36.00% |
| Month | -28.89% |
| Quarter | +6.67% |
| 6 Months | +113.33% |
| YTD | +113.33% |
| Year | -82.61% |
| 3 Years | -97.59% |
| 5 Years | -99.41% |
| 10 Years | -99.24% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.32 | 0 |
| 2026-06-17 | $0.32 | 100 |
| 2026-06-16 | $0.34 | 300 |
| 2026-06-15 | $0.45 | 100 |
| 2026-06-12 | $0.50 | 100 |
| 2026-06-11 | $0.50 | 100 |
| 2026-06-10 | $0.40 | 1,900 |
| 2026-06-09 | $0.40 | 1,700 |
| 2026-06-08 | $0.50 | 0 |
| 2026-06-05 | $0.50 | 100 |
| 2026-06-04 | $0.49 | 100 |
| 2026-06-03 | $0.59 | 100 |
| 2026-06-02 | $0.50 | 300 |
| 2026-06-01 | $0.01 | 500 |
| 2026-05-29 | $0.59 | 100 |
| 2026-05-28 | $0.59 | 100 |
| 2026-05-27 | $0.45 | 100 |
| 2026-05-26 | $0.45 | 9,500 |
| 2026-05-22 | $0.59 | 100 |
| 2026-05-21 | $0.01 | 3,700 |
| 2026-05-20 | $0.45 | 0 |
| 2026-05-19 | $0.45 | 100 |
About Orgenesis Inc.
Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.
đ° Latest News
No news articles available at the moment. Check back later for updates on ORGS.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $16,085,000 | $26,049,000 | $28,015,000 |
| Cost Of Revenue | $16,878,000 | $27,066,000 | $28,889,000 |
| Total Revenue | $530,000 | $36,025,000 | $35,502,000 |
| Operating Revenue | $530,000 | $36,025,000 | $35,502,000 |
| Expenses | |||
| Interest Expense | $2,167,000 | $1,824,000 | $943,000 |
| Total Expenses | $55,421,000 | $43,566,000 | $50,024,000 |
| Rent Expense Supplemental | $161,000 | $199,000 | $249,000 |
| Other Income Expense | $-7,380,000 | $-2,593,000 | $-2,711,000 |
| Other Non Operating Income Expenses | $4,000 | $173,000 | - |
| Net Non Operating Interest Income Expense | $-2,174,000 | $-1,826,000 | $-718,000 |
| Total Other Finance Cost | $7,000 | $2,000 | $-225,000 |
| Interest Expense Non Operating | $2,167,000 | $1,824,000 | $943,000 |
| Operating Expense | $38,543,000 | $16,500,000 | $21,135,000 |
| Other Operating Expenses | $2,688,000 | $-173,000 | $-2,278,000 |
| General And Administrative Expense | $34,624,000 | $15,065,000 | $14,091,000 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-55,361,000 | $-14,889,000 | $-18,053,000 |
| Net Interest Income | $-2,174,000 | $-1,826,000 | $-718,000 |
| Normalized Income | $-50,107,500 | $-13,895,180 | $-16,272,530 |
| Net Income From Continuing And Discontinued Operation | $-55,361,000 | $-14,889,000 | $-18,053,000 |
| Total Operating Income As Reported | $-53,636,000 | $-10,110,000 | $-16,800,000 |
| Net Income Common Stockholders | $-55,361,000 | $-14,889,000 | $-18,053,000 |
| Net Income | $-55,361,000 | $-14,889,000 | $-18,053,000 |
| Net Income Including Noncontrolling Interests | $-64,918,000 | $-12,169,000 | $-18,059,000 |
| Net Income Continuous Operations | $-64,918,000 | $-12,169,000 | $-18,059,000 |
| Pretax Income | $-64,445,000 | $-11,960,000 | $-17,951,000 |
| Special Income Charges | $-6,325,000 | $-1,113,000 | $-1,865,000 |
| Earnings From Equity Interest | $-734,000 | $-1,508,000 | $-272,000 |
| Operating Income | $-54,891,000 | $-7,541,000 | $-14,522,000 |
| Depreciation Amortization Depletion Income Statement | $767,000 | $961,000 | $990,000 |
| Depreciation And Amortization In Income Statement | $767,000 | $961,000 | $990,000 |
| Amortization Of Intangibles Income Statement | $721,000 | $911,000 | $948,000 |
| Depreciation Income Statement | $46,000 | $50,000 | $42,000 |
| Gross Profit | $-16,348,000 | $8,959,000 | $6,613,000 |
| Net Income Discontinuous Operations | - | - | $0 |
| Per Share | |||
| Diluted EPS | $-19.10 | $-5.90 | $-7.40 |
| Basic EPS | $-19.10 | $-5.90 | $-7.40 |
| Other | |||
| Tax Effect Of Unusual Items | $-1,396,500 | $-264,180 | $-658,530 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-54,068,000 | $-6,900,000 | $-12,705,000 |
| Total Unusual Items | $-6,650,000 | $-1,258,000 | $-2,439,000 |
| Total Unusual Items Excluding Goodwill | $-6,650,000 | $-1,258,000 | $-2,439,000 |
| Reconciled Depreciation | $1,560,000 | $1,978,000 | $1,864,000 |
| EBITDA (Bullshit earnings) | $-60,718,000 | $-8,158,000 | $-15,144,000 |
| EBIT | $-62,278,000 | $-10,136,000 | $-17,008,000 |
| Diluted Average Shares | $2,900,786 | $2,509,628 | $2,427,365 |
| Basic Average Shares | $2,900,786 | $2,509,628 | $2,427,365 |
| Diluted NI Availto Com Stockholders | $-55,361,000 | $-14,889,000 | $-18,053,000 |
| Minority Interests | $9,557,000 | $-2,720,000 | $6,000 |
| Tax Provision | $473,000 | $209,000 | $108,000 |
| Gain On Sale Of Business | $-5,343,000 | $0 | - |
| Other Special Charges | $283,000 | $52,000 | $1,865,000 |
| Write Off | $699,000 | $0 | - |
| Impairment Of Capital Assets | $0 | $1,061,000 | $0 |
| Gain On Sale Of Security | $-325,000 | $-145,000 | $-574,000 |
| Provision For Doubtful Accounts | $2,688,000 | $0 | - |
| Amortization | $721,000 | $911,000 | $948,000 |
| Research And Development | $464,000 | $474,000 | $8,332,000 |
| Selling General And Administration | $34,624,000 | $15,065,000 | $14,091,000 |
| Other Gand A | $31,389,000 | $10,496,000 | $6,620,000 |
| Rent And Landing Fees | $161,000 | $199,000 | $249,000 |
| Salaries And Wages | $3,074,000 | $4,370,000 | $7,222,000 |
| Otherunder Preferred Stock Dividend | - | - | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-29,569,000 | $9,680,000 | $18,264,000 |
| Total Assets | $14,552,000 | $90,928,000 | $59,841,000 |
| Total Non Current Assets | $10,476,000 | $44,610,000 | $34,083,000 |
| Other Non Current Assets | $18,000 | $1,022,000 | $805,000 |
| Non Current Prepaid Assets | $38,000 | $331,000 | $363,000 |
| Non Current Deferred Assets | $0 | $103,000 | $0 |
| Non Current Deferred Taxes Assets | $0 | $103,000 | $0 |
| Non Current Note Receivables | $0 | $96,000 | $821,000 |
| Goodwill And Other Intangible Assets | $8,586,000 | $17,881,000 | $20,224,000 |
| Other Intangible Assets | $7,375,000 | $9,694,000 | $11,821,000 |
| Current Assets | $4,076,000 | $46,318,000 | $25,758,000 |
| Restricted Cash | $642,000 | $1,058,000 | $501,000 |
| Inventory | $34,000 | $120,000 | $118,000 |
| Receivables | $2,563,000 | $39,829,000 | $19,666,000 |
| Other Receivables | $2,017,000 | $958,000 | $1,357,000 |
| Loans Receivable | $0 | $2,688,000 | $3,064,000 |
| Accounts Receivable | $88,000 | $36,183,000 | $15,245,000 |
| Allowance For Doubtful Accounts Receivable | $0 | $0 | - |
| Gross Accounts Receivable | $88,000 | $36,183,000 | - |
| Cash Cash Equivalents And Short Term Investments | $837,000 | $5,311,000 | $5,473,000 |
| Cash And Cash Equivalents | $837,000 | $5,311,000 | $5,473,000 |
| Prepaid Assets | - | - | $1,188,000 |
| Debt | |||
| Net Debt | $21,450,000 | $12,536,000 | $5,266,000 |
| Total Debt | $22,621,000 | $20,272,000 | $11,840,000 |
| Long Term Debt And Capital Lease Obligation | $19,067,000 | $15,166,000 | $5,456,000 |
| Long Term Debt | $18,967,000 | $13,343,000 | $4,854,000 |
| Current Debt And Capital Lease Obligation | $3,554,000 | $5,106,000 | $6,384,000 |
| Current Debt | $3,320,000 | $4,504,000 | $5,885,000 |
| Other Current Borrowings | $3,320,000 | $4,504,000 | $5,885,000 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $35,535,000 | $31,654,000 | $21,210,000 |
| Total Non Current Liabilities Net Minority Interest | $19,128,000 | $15,744,000 | $5,845,000 |
| Other Non Current Liabilities | $61,000 | $415,000 | $288,000 |
| Current Liabilities | $16,407,000 | $15,910,000 | $15,365,000 |
| Current Deferred Liabilities | $2,180,000 | $1,578,000 | $1,297,000 |
| Payables And Accrued Expenses | $10,673,000 | $9,226,000 | $7,684,000 |
| Payables | $8,455,000 | $6,578,000 | $7,199,000 |
| Other Payable | $1,079,000 | $1,860,000 | $1,907,000 |
| Total Tax Payable | $740,000 | $289,000 | $54,000 |
| Income Tax Payable | $740,000 | $289,000 | $54,000 |
| Accounts Payable | $6,451,000 | $4,429,000 | $5,238,000 |
| Non Current Deferred Liabilities | - | $144,000 | $0 |
| Equity | |||
| Common Stock Equity | $-20,983,000 | $27,561,000 | $38,488,000 |
| Total Equity Gross Minority Interest | $-20,983,000 | $59,274,000 | $38,631,000 |
| Stockholders Equity | $-20,983,000 | $27,561,000 | $38,488,000 |
| Gains Losses Not Affecting Retained Earnings | $65,000 | $-270,000 | $207,000 |
| Other Equity Adjustments | $65,000 | $-270,000 | $207,000 |
| Retained Earnings | $-176,622,000 | $-121,261,000 | $-106,372,000 |
| Long Term Equity Investment | $8,000 | $39,000 | $152,000 |
| Preferred Securities Outside Stock Equity | - | $30,203,000 | $0 |
| Other | |||
| Treasury Shares Number | $28,656 | $28,656 | $23,125 |
| Ordinary Shares Number | $3,187,706 | $2,554,575 | $2,428,079 |
| Share Issued | $3,216,362 | $2,583,231 | $2,451,204 |
| Tangible Book Value | $-29,569,000 | $9,680,000 | $18,264,000 |
| Invested Capital | $1,304,000 | $45,408,000 | $49,227,000 |
| Working Capital | $-12,331,000 | $30,408,000 | $10,393,000 |
| Capital Lease Obligations | $334,000 | $2,425,000 | $1,101,000 |
| Total Capitalization | $-2,016,000 | $40,904,000 | $43,342,000 |
| Minority Interest | $0 | $31,713,000 | $143,000 |
| Treasury Stock | $1,266,000 | $1,266,000 | $1,266,000 |
| Additional Paid In Capital | $156,837,000 | $150,355,000 | $145,916,000 |
| Capital Stock | $3,000 | $3,000 | $3,000 |
| Common Stock | $3,000 | $3,000 | $3,000 |
| Employee Benefits | $0 | $163,000 | $101,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $0 | $163,000 | $101,000 |
| Long Term Capital Lease Obligation | $100,000 | $1,823,000 | $602,000 |
| Current Deferred Revenue | $2,180,000 | $1,578,000 | $1,297,000 |
| Current Capital Lease Obligation | $234,000 | $602,000 | $499,000 |
| Current Accrued Expenses | $2,218,000 | $2,648,000 | $485,000 |
| Dueto Related Parties Current | $185,000 | $0 | - |
| Investments And Advances | $8,000 | $39,000 | $584,000 |
| Goodwill | $1,211,000 | $8,187,000 | $8,403,000 |
| Net PPE | $1,826,000 | $25,138,000 | $11,286,000 |
| Accumulated Depreciation | $-575,000 | $-3,952,000 | $-2,940,000 |
| Gross PPE | $2,401,000 | $29,090,000 | $14,226,000 |
| Construction In Progress | $692,000 | $17,442,000 | $6,181,000 |
| Other Properties | $1,412,000 | $7,115,000 | $3,450,000 |
| Machinery Furniture Equipment | $297,000 | $4,533,000 | $4,595,000 |
| Raw Materials | $34,000 | $120,000 | - |
| Duefrom Related Parties Current | $458,000 | $0 | - |
| Non Current Deferred Revenue | - | $144,000 | $0 |
| Investmentsin Associatesat Cost | - | - | $152,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-16,933,000 | $-37,340,000 | $-34,732,000 |
| Operating Activities | |||
| Operating Cash Flow | $-14,837,000 | $-24,924,000 | $-26,866,000 |
| Cash Flow From Continuing Operating Activities | $-14,837,000 | $-24,924,000 | $-26,866,000 |
| Operating Gains Losses | $6,587,000 | $1,892,000 | $2,478,000 |
| Investing Activities | |||
| Capital Expenditure | $-2,096,000 | $-12,416,000 | $-7,866,000 |
| Investing Cash Flow | $-3,707,000 | $-14,133,000 | $-12,384,000 |
| Cash Flow From Continuing Investing Activities | $-3,707,000 | $-14,133,000 | $-12,384,000 |
| Net Other Investing Changes | $55,000 | $-2,811,000 | $-4,248,000 |
| Financing Activities | |||
| Issuance Of Capital Stock | $5,283,000 | $2,181,000 | $1,926,000 |
| Financing Cash Flow | $13,618,000 | $39,578,000 | $-106,000 |
| Cash Flow From Continuing Financing Activities | $13,618,000 | $39,578,000 | $-106,000 |
| Net Other Financing Charges | $5,000,000 | $20,593,000 | - |
| Net Common Stock Issuance | $5,283,000 | $2,181,000 | $910,000 |
| Common Stock Issuance | $5,283,000 | $2,181,000 | $1,926,000 |
| Repurchase Of Capital Stock | - | $0 | $-1,016,000 |
| Other | |||
| Repayment Of Debt | $-3,035,000 | $-2,346,000 | $-1,016,000 |
| Issuance Of Debt | $6,370,000 | $19,150,000 | $0 |
| Interest Paid Supplemental Data | $785,000 | $458,000 | $443,000 |
| End Cash Position | $1,479,000 | $6,369,000 | $5,974,000 |
| Beginning Cash Position | $6,369,000 | $5,974,000 | $45,568,000 |
| Effect Of Exchange Rate Changes | $36,000 | $-126,000 | $-238,000 |
| Changes In Cash | $-4,926,000 | $521,000 | $-39,356,000 |
| Net Issuance Payments Of Debt | $3,335,000 | $16,804,000 | $-1,016,000 |
| Net Short Term Debt Issuance | $-35,000 | $-46,000 | $-16,000 |
| Short Term Debt Payments | $-35,000 | $-46,000 | $-16,000 |
| Net Long Term Debt Issuance | $3,370,000 | $16,850,000 | $-1,000,000 |
| Long Term Debt Payments | $-3,000,000 | $-2,300,000 | $-1,000,000 |
| Long Term Debt Issuance | $6,370,000 | $19,150,000 | $0 |
| Net Investment Purchase And Sale | $-33,000 | $-14,000 | $-28,000 |
| Purchase Of Investment | $-33,000 | $-14,000 | $-28,000 |
| Net Business Purchase And Sale | $-1,633,000 | $862,000 | $-242,000 |
| Sale Of Business | $0 | $862,000 | $0 |
| Purchase Of Business | $-1,633,000 | $0 | $-242,000 |
| Net PPE Purchase And Sale | $-2,096,000 | $-12,170,000 | $-7,866,000 |
| Sale Of PPE | $0 | $246,000 | $0 |
| Purchase Of PPE | $-2,096,000 | $-12,416,000 | $-7,866,000 |
| Change In Working Capital | $36,626,000 | $-19,979,000 | $-15,397,000 |
| Change In Other Working Capital | $-19,000 | $-319,000 | $487,000 |
| Change In Other Current Assets | $13,000 | $26,000 | $-18,000 |
| Change In Payables And Accrued Expense | $6,529,000 | $981,000 | $-4,003,000 |
| Change In Accrued Expense | $1,013,000 | $2,302,000 | $-248,000 |
| Change In Payable | $5,516,000 | $-1,321,000 | $-3,755,000 |
| Change In Account Payable | $5,516,000 | $-1,321,000 | $-3,755,000 |
| Change In Prepaid Assets | $432,000 | $391,000 | $260,000 |
| Change In Inventory | $-389,000 | $-7,000 | $55,000 |
| Change In Receivables | $30,060,000 | $-21,051,000 | $-12,178,000 |
| Changes In Account Receivables | $30,060,000 | $-21,051,000 | $-12,178,000 |
| Other Non Cash Items | $1,458,000 | $1,311,000 | $503,000 |
| Stock Based Compensation | $463,000 | $982,000 | $1,745,000 |
| Provisionand Write Offof Assets | $2,688,000 | - | - |
| Asset Impairment Charge | $699,000 | $1,061,000 | $0 |
| Depreciation Amortization Depletion | $1,560,000 | $1,978,000 | $1,864,000 |
| Depreciation And Amortization | $1,560,000 | $1,978,000 | $1,864,000 |
| Amortization Cash Flow | $721,000 | $911,000 | - |
| Amortization Of Intangibles | $721,000 | $911,000 | - |
| Depreciation | $839,000 | $1,067,000 | - |
| Earnings Losses From Equity Investments | $734,000 | $1,508,000 | $272,000 |
| Gain Loss On Investment Securities | $2,688,000 | - | - |
| Net Foreign Currency Exchange Gain Loss | $227,000 | $502,000 | $341,000 |
| Gain Loss On Sale Of Business | $5,343,000 | $0 | $0 |
| Net Income From Continuing Operations | $-64,918,000 | $-12,169,000 | $-18,059,000 |
| Common Stock Payments | - | $0 | $-1,016,000 |
| Sale Of Investment | - | - | $0 |
Fetched: 2026-02-02